Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-22-046521
Filing Date
2022-04-15
Accepted
2022-04-15 17:00:39
Documents
1
Period of Report
2022-02-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2212832-1_3aseq1.html 3/A  
1 OWNERSHIP DOCUMENT tm2212832-1_3aseq1.xml 3/A 2573
  Complete submission text file 0001104659-22-046521.txt   4146
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELLECTAR BIOSCIENCES, INC. 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address
Kolean Chad J (Reporting) CIK: 0001616753 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36598 | Film No.: 22830523